确保Gleason分级与时俱进：该如何称呼Gleason 6级前列腺癌？
Future-proofing Gleason Grading: What to Call Gleason 6 Prostate Cancer?
作者信息
Loeb Stacy, Montorsi Francesco, Catto James W
机构信息
Department of Urology and Population Health, New York University, NY, USA.
Division of Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Milan, Italy.
出版信息
Eur Urol. 2015 Jul;68(1):1-2. doi: 10.1016/j.eururo.2015.02.038. Epub 2015 Mar 11.
Abstract
At the 2014 International Society of Urological Pathology meeting, changes to prostate cancer grading were discussed including new prognostic Gleason grade groups 1-5 representing Gleason scores of 3+3, 3+4, 4+3, 8, and 9-10, respectively.
摘要
在2014年国际泌尿病理学会会议上，讨论了前列腺癌分级的变化，包括新的预后Gleason分级组1-5，分别代表Gleason评分3+3、3+4、4+3、8和9-10。
相似文献
1
Future-proofing Gleason Grading: What to Call Gleason 6 Prostate Cancer?确保Gleason分级与时俱进：该如何称呼Gleason 6级前列腺癌？
Eur Urol. 2015 Jul;68(1):1-2. doi: 10.1016/j.eururo.2015.02.038. Epub 2015 Mar 11.
2
Prostate cancer: from Gleason scoring to prognostic grade grouping.前列腺癌：从 Gleason 评分到预后分级分组
Expert Rev Anticancer Ther. 2016;16(4):433-40. doi: 10.1586/14737140.2016.1160780.
3
International Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary grading.国际泌尿病理学会（ISUP）前列腺癌分级——当代分级的ISUP共识
APMIS. 2016 Jun;124(6):433-5. doi: 10.1111/apm.12533.
4
From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer.从前列腺癌的格里森分级到国际泌尿病理学会（ISUP）分级
Scand J Urol. 2016 Oct;50(5):325-9. doi: 10.1080/21681805.2016.1201858. Epub 2016 Jul 14.
5
The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.2005年国际泌尿病理学会共识会议对前列腺穿刺活检中前列腺癌Gleason分级标准的影响。
J Urol. 2008 Aug;180(2):548-52; discussion 552-3. doi: 10.1016/j.juro.2008.04.018. Epub 2008 Jun 11.
6
Implications of the International Society of Urological Pathology modified Gleason grading system.国际泌尿病理学会改良 Gleason 分级系统的意义。
Arch Pathol Lab Med. 2012 Apr;136(4):426-34. doi: 10.5858/arpa.2011-0495-RA.
7
The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer.2014年国际泌尿病理学会（ISUP）前列腺癌分级系统的预后意义。
Pathology. 2015 Oct;47(6):515-9. doi: 10.1097/PAT.0000000000000315.
8
Prostate cancer grading in 2018: limitations, implementations, cribriform morphology, and biological markers.2018年前列腺癌分级：局限性、实施情况、筛状形态及生物标志物
Int J Biol Markers. 2018 Nov;33(4):331-334. doi: 10.1177/1724600818781296. Epub 2018 Jun 27.
9
Contemporary Gleason grading and novel Grade Groups in clinical practice.临床实践中的当代Gleason分级及新型分级组
Curr Opin Urol. 2016 Sep;26(5):488-92. doi: 10.1097/MOU.0000000000000320.
10
Evolution, controversies and the future of prostate cancer grading.前列腺癌分级的演变、争议与未来
Pathol Int. 2019 Feb;69(2):55-66. doi: 10.1111/pin.12761. Epub 2019 Jan 29.
引用本文的文献
1
It's all in the name: Does nomenclature for indolent prostate cancer impact management and anxiety?这都在名字里：惰性前列腺癌的命名是否会影响管理和焦虑？
Cancer. 2021 Sep 15;127(18):3354-3360. doi: 10.1002/cncr.33621. Epub 2021 Jun 3.
2
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians.前列腺癌的当代分级：2017年病理学家和临床医生更新版
Asian J Androl. 2017 Aug 4;21(1):19-23. doi: 10.4103/aja.aja_24_17.
3
Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study.改善原发性前列腺癌诊断时的临床风险分层：一项预后建模研究。
PLoS Med. 2016 Aug 2;13(8):e1002063. doi: 10.1371/journal.pmed.1002063. eCollection 2016 Aug.
4
Perspectives of Prostate Cancer Patients on Gleason Scores and the New Grade Groups: Initial Qualitative Study.前列腺癌患者对 Gleason 评分和新分级组的看法：初步定性研究
Eur Urol. 2016 Dec;70(6):1083-1085. doi: 10.1016/j.eururo.2016.05.039. Epub 2016 Jun 7.
5
MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer.微小RNA作为前列腺癌诊断、预后及治疗诊断学的生物标志物
Int J Mol Sci. 2016 Mar 22;17(3):421. doi: 10.3390/ijms17030421.
6
Two-dimensional neovascular complexity is significantly higher in nontumor prostate tissue than in low-risk prostate cancer.二维新生血管复杂性在非肿瘤性前列腺组织中显著高于低风险前列腺癌。
Korean J Urol. 2015 Jun;56(6):435-42. doi: 10.4111/kju.2015.56.6.435. Epub 2015 Jun 2.
本文引用的文献
1
Active surveillance for prostate cancer: the role of the pathologist.前列腺癌的主动监测：病理学家的作用。
Pathology. 2015 Jan;47(1):1-3. doi: 10.1097/PAT.0000000000000186.
2
Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.密歇根州低危前列腺癌男性中初始主动监测的当代应用。
Eur Urol. 2015 Jan;67(1):44-50. doi: 10.1016/j.eururo.2014.08.024. Epub 2014 Aug 24.
3
Addressing overdiagnosis and overtreatment in cancer: a prescription for change.解决癌症的过度诊断和过度治疗问题：变革的良方。
Lancet Oncol. 2014 May;15(6):e234-42. doi: 10.1016/S1470-2045(13)70598-9.
4
When is prostate cancer really cancer?前列腺癌何时才是真正的癌症？
Urol Clin North Am. 2014 May;41(2):339-46. doi: 10.1016/j.ucl.2014.01.006. Epub 2014 Feb 21.
5
Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.前瞻性研究比较了经直肠超声引导活检与磁共振（MR）成像引导活检在无既往前列腺活检史男性中的前列腺癌检出率。
Eur Urol. 2014 Jul;66(1):22-9. doi: 10.1016/j.eururo.2014.03.002. Epub 2014 Mar 14.
6
Tracking the clonal origin of lethal prostate cancer.追踪致命性前列腺癌的克隆起源。
J Clin Invest. 2013 Nov;123(11):4918-22. doi: 10.1172/JCI70354. Epub 2013 Oct 25.
7
Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer.基于人群的研究：低危和中危前列腺癌采用主动监测和观察等待的使用情况及其决定因素。
J Urol. 2013 Nov;190(5):1742-9. doi: 10.1016/j.juro.2013.05.054. Epub 2013 May 30.
8
Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.预后格里森分级分组：基于改良格里森评分系统的数据。
BJU Int. 2013 May;111(5):753-60. doi: 10.1111/j.1464-410X.2012.11611.x. Epub 2013 Mar 6.
9
Gleason score 6 adenocarcinoma: should it be labeled as cancer?Gleason评分6级腺癌：是否应将其标记为癌症？
J Clin Oncol. 2012 Dec 10;30(35):4294-6. doi: 10.1200/JCO.2012.44.0586. Epub 2012 Oct 1.
10
Risk of Gleason grade inaccuracies in prostate cancer patients eligible for active surveillance.适合主动监测的前列腺癌患者中格里森分级不准确的风险。
Urology. 2012 Sep;80(3):661-6. doi: 10.1016/j.urology.2012.06.022.
Zotero 插件